Institute for Advanced Discovery & Innovation
Richard Berman is director of the Patel College of Global Sustainability, visiting social entrepreneurship
professor in the Muma College of Business, and a professor in the institute. A recognized
global leader in health care education and management, he has consulted for the Commissioner
of the U.S. Food and Drug Administration, the U.S. Department of Health and Human
Services, McKinsey & Company, and the government of Rwanda. He has served as New York
State Commissioner of Housing and Economic Development and trustee of the State University
of New York, as well as on the Commission on Advancement of Racial and Ethnic Equality
of the American Council on Education, the Division III President's Council of NCAA,
ProPAC, and the New York State's Commissioner's Advisory Council on Higher Education.
He was advisor to the Joint Special Representative of the African Union—United Nations
Mission in Darfur (UNAMID)—the then-largest peacekeeping operation in the world. He
was Manhattanville College's tenth President and is credited with turning the struggling
college into a high-ranking liberal arts college. Previously, he was the executive
vice president of NYU Medical Center and professor of health care management at the
NYU School of Medicine. He is a member of the NAM and on the boards of EmblemHealth,
Seeds of Peace, and the Savannah Centre for Diplomacy, Democracy and Development in
Abuja, Nigeria. He received his BBA, MBA, and MPH from the University of Michigan
in Ann Arbor and holds honorary doctorates from Manhattanville College and New York
Robert H. Byrne is a Distinguished University Professor in the College of Marine Science at USF.
He holds a BS degree in physics from the University of Chicago, an MS in physics from
DePaul University, an MA in chemistry from Boston University, and a PhD in oceanography
from the University of Rhode Island. He has made important contributions in the field
of marine physical chemistry — specifically, investigating the speciation of trace
metals in seawater, developing new procedures for characterizing the carbon dioxide
(CO2) system in aqueous environments, and designing new instrumentation for measuring
nutrients, trace elements, and CO2 system constituents in freshwater and seawater.
His field research has included more than 560 days at sea in the Gulf of Mexico and
the Atlantic, Pacific, Indian, and Arctic Oceans. He holds fourteen U.S. and international
patents and is one of the co-founders of Ocean Optics, Inc. He has written 200 peer-reviewed
publications, serving as first or second author on two-thirds of these. He has also
served as a reviewer and editor for various agencies and academic journals, including
more than two decades as an associate editor for the journal Geochemica et Cosmochimica Acta. He is a fellow of the American Geophysical Union, the AAAS, and the NAI.
William Cavanaugh III is a professor in the institute and was the chairman and CEO of Progress Energy until
his retirement in 2004. After completing his BS in mechanical engineering at Tulane
University in 1961, he joined the U.S. Navy and became a nuclear submarine officer.
Upon his honorable discharge, he began his long and productive career in the utility
industry, holding key executive positions at Arkansas Power & Light, Louisiana Power
& Light, and Mississippi Power & Light. His success in guiding these companies led
to his taking over Carolina Power & Light, where he served as president and COO and
later as CEO and chairman, leading the company to financial success and new levels
of efficiency in its operations and power generation. In 2000, he negotiated the purchase
of Florida Progress Corporation, merging it with CP&L to become Progress Energy, a
Fortune 500 energy company serving over three million customers. After his retirement
from Progress Energy, he became chairman of the World Association for Nuclear Operations
(WANO), where he oversaw the institution of a mandatory peer review process for member
organizations, among other initiatives. He was elected as a member of the NAE in 2001
for "contributions to excellence in the generation of electricity from nuclear power
by establishing and achieving exemplary levels of performance." He has received the
William S. Lee Award for Industry Leadership from the Nuclear Energy Institute and
the Walter H. Zinn Award from the American Nuclear Society.
Selim Chacour is a professor in the institute and was the principal founder of American Hydro Corporation,
which, under his leadership, became an industry leader in hydro turbine upgrades.
In his industry, he is hailed for various improvements to the design of turbine components
and for completely revolutionizing runner design by creating computer design programs
which obviated the need for physical model testing, the previous standard. This work
had a great impact on hydro plants already in existence, allowing them to upgrade
their facilities and improve performance. His turbine runner designs have been used
in such iconic structures as the Aswan High Dam in Egypt and the Hoover Dam in the
United States. Additionally, his designs have generated concrete improvements in efficiency,
resulting in gains in power generation and reductions in costs and environmental impact.
Lauded as a visionary, he was elected as a member of the NAE "for pioneering three-dimensional
finite element computations in mechanical and hydraulic design, leadership in hydro
turbine research and development, and business stewardship," highlighting his status
as an innovator and as a business leader. He is also the recipient of the National
Hydropower Association's Henwood Award, the industry's highest honor, and holds eight
U.S. patents for his work. In 2015, he became a fellow of the NAI.
David M. Eddy is a professor in the institute and a physician, mathematician, and health care analyst
who has done seminal work in mathematical modeling of diseases, clinical practice
guidelines, and evidence-based medicine. In summarizing his career, the NAM (of which
he is a member) emphasized his innovative thinking and practices, noting that "more
than 25 years ago, Eddy wrote the seminal paper on the role of guidelines in medical
decision-making, the first Markov model applied to clinical problems, and the original
criteria for coverage decisions; he was the first to use and publish the term 'evidence-based'."
He was a professor at Stanford University and the J. Alexander McMahon Professor at
Duke University before he left academia to become an independent researcher and entrepreneur.
He founded Archimedes Inc., a health care modeling company, and was chief medical
officer until he retired in 2013. The author of five books and more than 100 first-authored
papers, including a series of 28 in the Journal of the American Medical Association, his writings span from technical mathematical theories to broad health policy topics.
He has received 10 national and international awards in several fields, including
applied mathematics, health technology assessment, health care quality, environmental
sciences, and outcomes research, as well as awards from five organizations for lifetime
achievement. In 2012, he was ranked the 13th most innovative person in health care
by "Health Future 100." In 2015, he became a fellow of the NAI. He holds two U.S.
Michael W. Fountain serves as the founding director of USF's Center for Entrepreneurship, which has been
ranked by Princeton Review and Entrepreneur Magazine as one of the top 25 entrepreneurship educational programs in the United States for
the past nine years. He serves both as a professor in industrial and management systems
engineering, psychiatry and behavioral medicine, and pharmacy and as the John and
Beverley Grant Endowed Chair in Entrepreneurship in the Muma College of Business.
Holding more than 60 U.S. and foreign patents, which are used in over 150 healthcare
and consumer products worldwide, he is a fellow of the NAI and a founding member of
its USF chapter. He has focused the past 30 years on creating, financing, growing,
and harvesting biotechnology, medical device, and life sciences companies. He has
founded or co-founded 12 new ventures, three of which became publicly traded companies.
He has served in a variety of corporate leadership roles, including chief scientific
officer, chief executive officer, and chairman of the board. He is the author of numerous
peer reviewed articles on micro- and nano-drug delivery systems and entrepreneurship
theory and practice. He received his Honors BS from Samford University, his MS and
PhD from Auburn University, and his MBA from Bristol University.
Richard D. Gitlin is a State of Florida 21st Century World Class Scholar, Distinguished University
Professor, and the Agere Systems Chair of Electrical Engineering at the University
of South Florida. He has more than 45 years of leadership in the communications industry
and in academia, and he has a record of significant research contributions that have
been sustained and prolific over several decades. His research focuses on the intersection
of communications with medicine, especially in vivo wireless communications and networking
that is used to advance minimally invasive surgery and other cyber-physical health
care systems. Before joining the faculty at USF, Gitlin was at Bell Labs/Lucent Technologies,
where he was the co-inventor of Digital Subscriber Line (DSL), and at his retirement,
he was senior VP for communications and networking research. He is a member of the
NAE, Fellow of the IEEE, Bell Laboratories Fellow, Charter Fellow of the NAI, and
co-recipient of the Thomas Alva Edison Patent Award and the S.O. Rice Prize. He has
co-authored a text, published 100 papers, and holds 55 U.S. patents. He is currently
working on MARVEL, a robotic imaging system used to aid minimally invasive surgery,
and is partnering with Jabil to develop sensors that can collect and wirelessly transmit
potentially life-saving physiological data.
D. Yogi Goswami is Distinguished University Professor, John and Naida Ramil Professor of Chemical
Engineering, and director of the Clean Energy Research Center at the University of
South Florida. His research focuses on solar energy fundamentals and applications,
energy storage, thermodynamics, indoor air quality (IAQ), HVAC, hydrogen, and fuel
cells. He is editor-in-chief of Solar Energy and Progress in Solar Energy and author/editor of 18 books, 16 book chapters, six conference proceedings, and
over 350 refereed papers. He also holds 18 U.S. patents. He is an NAI Charter Fellow,
a fellow of ASME International, ASHRAE, and ASES, and a member of the Pan American
Academy of Engineering. He has received the ISES' Farrington Daniels Award, ASME's
Frank Kreith Energy medal, ASME's John Yellott Award for Solar Energy, and the ASES'
Charles Greely Abbott award. He is a 2016 inductee of the Florida Inventors Hall of
Stephen B. Liggett is associate vice president of USF Health, vice dean for research in the Morsani
College of Medicine, and professor of internal medicine and molecular pharmacology
and physiology at the University of South Florida. He discovered and characterized
receptor polymorphisms. He was the first to discover polymorphisms of the G-protein
coupled receptor superfamily, to which more than 50% of all drugs are targeted. This
discovery moved the field of pharmacogenomics from one that concentrated on metabolizing
enzymes to one that includes target proteins for determining drug responsiveness.
He also developed biotechnical companies related to personalized medicine based on
these discoveries. His fundamental studies in humans and genetically altered mice
have led to new advances in the areas of heart failure, hypertension, and obstructive
lung diseases. He holds 16 U.S. patents and has more than 235 publications. He is
a fellow of the American College of Chest Physicians and the National Academy of Inventors,
as well as the recipient of the Frontiers in Pharmacology Award from Case Western
Reserve University and Excellence in Science Award from Thomas Jefferson University.
Charles J. Lockwood, senior vice president of USF Health and dean of the Morsani College of Medicine
at USF, is internationally known for research expertise in uterine hemostasis and
preterm birth. Previously, he was dean of The Ohio State University College of Medicine;
Anita O'Keeffe Young Professor and chair of obstetrics and gynecology at the Yale
School of Medicine; and chair of obstetrics and gynecology at the NYU School of Medicine
and interim director of their NCI-designated Cancer Center. He graduated from Brown
University, received his MD from the University of Pennsylvania, served a residency
at Pennsylvania Hospital and a Maternal-Fetal Medicine fellowship at Yale. He also
holds a master's in health care management from Harvard. He has garnered multiple
NIH and March of Dimes grants and published over 280 peer reviewed papers (h-index
of 66). He has co-edited five obstetrical textbooks, three with multiple editions;
serves on multiple editorial boards; and is editor-in-chief of Contemporary OB/GYN, where his editorials have garnered five national awards. He has served on multiple
NIH study sections, chaired FDA and American College of Obstetricians and Gynecologists
committees, is secretary of the American Gynecological and Obstetrical Society, and
sits on the National Board of the March of Dimes Foundation. He is a member of the
Sigma Xi and Alpha Omega Alpha honor societies, former president of the Society for Reproductive Investigation and
winner of its Pardi Distinguished Scientist Award, and a member of the NAM. He maintains
an active research lab at USF.
Dean F. Martin is Distinguished University Professor Emeritus at USF, where he has been a member
of the faculty since 1964. Previously, he was a member of the faculty of the University
of Illinois as instructor and assistant professor of inorganic chemistry. He and his
wife, Barbara B. Martin, share research interests concerned with the coordination
chemistry of natural water systems, including problems of red tide and aquatic weeds.
The Martins were editors of the Florida Scientist from 1984-2010. He is the author or co-author of over 450 publications, including
six books. He received his BA from Grinnell College and his PhD from the Pennsylvania
State University. In 1958-59, he was a National Science Foundation postdoctoral fellow
at University College London. He later received a Career Development Award from the
Division of General Medical Sciences, NIH, to study the chemistry and chemical environment
of algal toxins. In 1970-71, he was a visiting professor of physiology and pharmacology
at Duke University Medical Center. He is the recipient of the Florida Award, the Civic
Service Award of the Florida Section, and the F. J. Zimmermann Award in Environmental
Science from the Central Wisconsin Section, sponsored by Zimpro Inc. He is also a
fellow of the AAAS and the NAI. Dean and Barbara Martin were the co-recipients of
the 1994 Medalist Award of the Florida Academy of Sciences, its highest award. He
has been active in the American Chemical Society, and he has held several positions
in the Aquatic Plant Management Society.
Shyam S. Mohapatra is Distinguished USF Health Professor, director of the Division of Translational Medicine
at the University of South Florida, and a research career scientist at the James A.
Haley VA Hospital in Tampa. He also directs the USF Center for Research and Education
in Nanobioengineering. He is recognized for his many inventions in the field of nanoscale
biomedical diagnostics and therapeutics in cancers, asthma, viral infections, and
traumatic brain injury. His inventions and co-inventions have led to several customized
cell-targeted nanoparticles with diverse drug payloads, a nano-HIV detection kit,
and, most recently, to a nanoscale platform for anti-cancer drug discovery and personalized
cancer treatment. He also serves as associate dean of graduate programs at the USF
College of Pharmacy and established a highly innovative online Master of Science program
in pharmaceutical nanotechnology. His research has brought USF over $20 million in
extramural funds, and he has published over 165 papers and holds over 30 U.S. and
foreign patents. His research has spawned inventions that have spun out companies.
He co-founded Transgenex Nanobiotech Inc, a USF spin-out company, which focuses on
commercializing nanoscale innovations. He is a Charter Fellow of the NAI, a fellow
of the American Academy of Allergy, Asthma & Immunology, and a 2014 inductee of the
Florida Inventors Hall of Fame.
Victor Poirier is a professor in the institute and former CEO and president of Thermo Cardiosystems
and chief technology advisor of Thoratec Corp. He is internationally recognized as
a pioneer for the design, development, clinical trial, and commercialization of first-generation
left-ventricular assist systems for treating heart failure. He is a founding fellow
of the American Institute for Medical and Biological Engineering and the International
Academy of Artificial Organ Pioneers of ICMT, a fellow of the National Academy of
Inventors, and a member of the NAE. He is the recipient of the Mediterranean Institute
of Cardiology Award (France), the Himet Award, and the Barney Clark Award from the
American Society for Artificial Internal Organs and was elected by his peers as the
national "Engineer of the Year" (Design News, 1992), among other honors and awards.
He holds 17 U.S. patents and has published over 110 papers. He is currently exploring
ways to teach innovation and innovative thinking practices.
Paul R. Sanberg is senior vice president for research, innovation and economic development, Distinguished
University Professor of neuroscience, biomedical engineering, and business at the
University of South Florida, and founder and president of the NAI. He is an inventor
on 111 U.S. and foreign patents and has worked as an executive with a number of startup
companies involved in cell therapy for degenerative disorders. His work has been instrumental
in translating novel pharmaceutical and cellular therapeutics to clinical trials for
Tourette syndrome, depression, stroke, Huntington's disease, Parkinson's disease,
ALS, and Alzheimer's disease. He is the 2015 Medalist of the Florida Academy of Sciences;
a 2015 inductee of the Florida Inventors Hall of Fame; fellow of the AAAS, American
Institute for Medical and Biological Engineering, and Royal Societies of Chemistry,
Public Health, and Medicine; Charter Fellow of the NAI; and AAAS-Lemelson Invention
Ambassador. He serves on the nomination evaluation committee of the United States
National Medal of Technology and Innovation with the U.S. Department of Commerce,
Smithsonian Innovation Festival selection committee, and advisory board of the APLU
Commission on Innovation, Competitiveness, and Economic Prosperity. He has published
more than 600 scientific articles and 14 books.
Lyle H. Schwartz is a professor in the institute and retired director, Air Force Office of Scientific
Research. He was formerly professor of materials science and engineering at Northwestern
University for 20 years and director of Northwestern's Materials Research Center for
five of those years. He then became director of the Materials Science and Engineering
Laboratory at the National Institute of Standards and Technology (NIST), where he
served for more than 12 years. After NIST, he moved to the Air Force Office of Scientific
Research, where, as director, he had responsibility for the entire basic research
program of the Air Force. He has played a significant role in shaping government policies
on many materials issues. He was elected as a member of the NAE for "leadership in
materials research and in coordinating industry and government collaboration in materials
engineering." He is a recipient of the Presidential rank of Meritorious Executive
of the government's Senior Executive Service, the Gold Medal Award of the Department
of Commerce, the National Materials Advancement Award of the Federation of Materials
Societies, and the Leadership Award of the Minerals, Metals, and Materials Society.
His current interests include government policy for R&D, particularly for materials
R&D, materials science education (STEM) at K-12 levels, and enhanced public understanding
of the roles and importance of technology in society. He is bringing his interests
in K-12 education to bear in the Tampa area as part of his commitment to USF and the
James Wynne is a professor in the institute and a senior member of the staff of IBM Research Headquarters. He manages the T. J. Watson Research Center's outreach to local schools and coordinates IBM's global participation in DiscoverE, serving as a catalyst to marshal the resources of IBM to enhance the Science, Technology, Engineering and Mathematics (STEM) education of K-12 students. His research contributions have been in nonlinear optics of semiconductors and insulators, nonlinear spectroscopy of atomic and molecular vapors, laser etching and fluorescence studies of human and animal tissue, and cluster science. He and two IBM colleagues discovered excimer laser surgery in 1981, laying the foundation for LASIK and PRK, techniques for surgically correcting myopia, astigmatism, and hyperopia. For this discovery, he has received many awards, including induction into the NIHF, the National Medal of Technology and Innovation, and the Russ Prize of the National Academy of Engineering (NAE). He is a member of the NAE, fellow of the NAI, member of the USF Chapter of the NAI, and a research collaborator with USF faculty. He holds 12 U.S. patents. His current research encompasses the development of novel applications of the excimer laser, especially its use as a "smart scalpel" for removing necrotic lesions of the skin while minimizing collateral damage to underlying and adjacent viable tissue.